TMDX REMAINS VERY UNDERVALUED 👇🏻
$TransMedics Group, Inc.(TMDX)$
PRICE TARGET: $195 --> $216
POTENTIAL UPSIDE: +76% ✅
"Q3 results were impressive, insane operating leverage, 16% margins in the weakest Q of the year. The earnings are bullish, but few will get it"
ASSUMPTIONS:
LTM Revenue: $0.566B
5Y Revenue CAGR: 23%
2030 Profit Margin: 23% --> 24%
2030 PE Ratio: 40
Shares outstanding: 0.0407B
Shares dilution: 2%/year
VALUATION:
Q3 2030 $TMDX SHARE PRICE =
0.566 * (1.23)^5 * 0.24 * 40 /
[0.0407 * (1.02)^5] = 340$
You can now choose the discount rate that you prefer, for Transmedics I want to use 12%
ACTUAL PRICE: $123
FAIR VALUE: $193
PRICE TARGET (1Y): $216
POTENTIAL UPSIDE: +73%
EXPECTED RETURNS: 22.6%/year
DIVIDEND YIELD: -
For whom haven't open CBA can know more from below:
🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!
Find out more here：
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
